跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,413 条关于
“tivozanib-nivolumab”
全部
2,413
临床试验
1,807
药物
30
机构
1
资讯
575
2年前
Tivozanib Monotherapy Shows Superiority Over Tivozanib Plus Nivolumab in Metastatic RCC After ICI Progression
2年前
TiNivo-2 Trial: Nivolumab Fails to Improve Outcomes in Advanced RCC After Prior ICI Therapy
去年
TiNivo-2 Trial Highlights Challenges in ICI Retreatment for Advanced RCC
去年
Tivozanib Monotherapy Shows Promise as Second-Line Treatment for Metastatic RCC Following Contemporary Immunotherapy
去年
TiNivo-2 Trial Shows No Added Benefit of Nivolumab Combination in IO-Refractory RCC Treatment
2年前
ESMO 2024: Optimizing Post-IO Therapy in Clear Cell and Expanding Options for Non-Clear Cell RCC
2年前
Dana-Farber Cancer Institute Presents Comprehensive Cancer Research at ESMO Congress 2024
去年
Tivozanib Monotherapy Shows Superior PFS Compared to Combination Therapy in Post-ICI Renal Cell Carcinoma
4年前
Exploring the Role of Immunotherapy After Progression in Renal Cell Carcinoma
去年
Keynote-522 Trial Demonstrates Overall Survival Benefit with Pembrolizumab in Triple-Negative Breast Cancer
第 1 页,共 58 页
上一页
下一页